The cardiovascular system medicine sales in Japan have seen fluctuating trends over the past decade. Starting at USD 12.86 billion in 2013, there were significant drops through 2015, a minor rebound in 2016, followed by consistent declines until hitting USD 8.16 billion in 2023. Notably, 2019 saw a substantial increase of 25.8% year-on-year, while the overall 5-year CAGR ending in 2023 was a positive 2.33%. However, the forecasted sales reveal a slight but steady decline, averaging a -0.16% annual decrease from 2023 to 2028.
Future trends to watch for include:
- Shifts in medical technology and innovation.
- Demographic changes, particularly in Japan's aging population.
- Regulatory changes and healthcare policies.
